Comments
Rossari Biotech has raised ₹148.87 crore from 15 anchor investors at ₹425 a share. Among them are Abu Dhabi Investment Authority, Ashoka India Opportunities, Goldman Sachs, HDFC Mutual Fund, Axis Mutual, HDFC Life, IIFL Special Opportunities, HSBC Global, Kotak Mahindra (International) and ICICI Prudential. The issue will open on July 13 and close on July 15 , with a price band of ₹423– ₹425 a share of face value of ₹ 2 each. The company proposed to raise ₹496.24 crore via the fresh issue of ₹50 crore and OFS of ₹446.25 crore. The net proceeds from the fresh issue to prepay or repay certain indebtedness, including accrued interest, fund working capital requirements and for general corporate purposes.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.